1986
DOI: 10.1097/00004424-198603000-00003
|View full text |Cite
|
Sign up to set email alerts
|

Intracoronary Administration of Streptokinase in a Canine Model: Disturbances in Thromboxane A2-Prostacyclin Balance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1988
1988
1992
1992

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…This large washout of thromboxane metabolites upon thrombolysis has been confirmed in dogs using intracoronary administration of streptokinase. 30 It is therefore likely that inhibition of thromboxane synthesis with an appropriate thromboxane synthetase inhibitor, or the blockade of thromboxane receptors with a potent thromboxane-receptor antagonist would prevent the untoward effects of TXA 2 in the coronary vasculature occurring during ischemia and establishment of a reperfused coronary vessel or vessels. Our results indicate that CGS-13080 totally blocked the rise in plasma TXB 2 concentration upon reperfusion, and that t-PA did not act as a thromboxane synthetase inhibitor.…”
Section: Discussionmentioning
confidence: 99%
“…This large washout of thromboxane metabolites upon thrombolysis has been confirmed in dogs using intracoronary administration of streptokinase. 30 It is therefore likely that inhibition of thromboxane synthesis with an appropriate thromboxane synthetase inhibitor, or the blockade of thromboxane receptors with a potent thromboxane-receptor antagonist would prevent the untoward effects of TXA 2 in the coronary vasculature occurring during ischemia and establishment of a reperfused coronary vessel or vessels. Our results indicate that CGS-13080 totally blocked the rise in plasma TXB 2 concentration upon reperfusion, and that t-PA did not act as a thromboxane synthetase inhibitor.…”
Section: Discussionmentioning
confidence: 99%